Back to search

NYSKAPNING-NYSKAPNING

TwinTarget ALS: Targeting microglia and as mast cells to revolutionise ALS Treatment

Awarded: NOK 0.50 mill.

Funding scheme:

NYSKAPNING-NYSKAPNING